Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma

Clinical trial NCT05286827 · TERMINATED

Trial details

NCT number: NCT05286827
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Acinar Cell Carcinoma

Start date: 2023-12-14
Primary completion: 2024-12-18
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.